Prognostic scores for predicting overall survival in patients with metastatic renal and urothelial cancer undergoing immunotherapy - which one to use?
mGPS, SII and NLR are scoring systems that are easy to record in routine clinical practice. As they provide good prediction of OS in patients with mUC and mRCC under IO, they may allow identification of patients at high-risk and monitor them more cautiously in addition to imaging.
Authors
- Jost von Hardenberg (ORCID: https://orcid.org/0000-0002-0728-681X)
- Thomas Stefan Worst (ORCID: https://orcid.org/0000-0001-5429-126X)
- Jonas Jarczyk (ORCID: https://orcid.org/0000-0003-4434-7826)
- Margarete Teresa Walach (ORCID: https://orcid.org/0000-0003-2053-5478)
- Frederik Wessels (ORCID: https://orcid.org/0000-0003-4213-8692)
- Britta Grüne (ORCID: https://orcid.org/0000-0003-1593-217X)
- Katja Nitschke
- Philipp Nuhn
- Ralph Burger
- Felix Brumm
Institutions
- Heidelberg University (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- University Medical Centre Mannheim (DE)
Publication Details
- Journal
- World Journal of Urology
- Published
- 2025-01-29
- DOI
- https://doi.org/10.1007/s00345-025-05452-4
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.01